isoxazoles has been researched along with Rheumatism in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martins-Filho, OA; Mota, LM; Oliveira, AC; Santos-Neto, LL; Simões, M; Tauil, PL | 1 |
| Mimori, T | 1 |
| Braddock, SR; Cassina, M; Chambers, CD; Jimenez, JL; Johnson, DL; Jones, KL; Luo, YJ; Mirrasoul, N; Robinson, LK; Salas, E; Xu, R | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Kellner, H; Schiemann, U | 1 |
| Kushwaha, SS; Mayer, DF | 1 |
| Chira, P; Sandborg, CI | 1 |
| Kremer, JM | 1 |
| Bolten, WW; Reiter, S | 1 |
| Arlt, AC; Brandt, J; Gross, WL; Metzler, C | 1 |
| Humbert, M; Simonneau, G | 1 |
| Bond, J; Finn, S; McCarthy, D; Quinn, C; Sheahan, K | 1 |
| Villiger, PM; von Esebeck, M; Østensen, M | 1 |
| Glück, T; Müller-Ladner, U | 1 |
| Robinson, DR | 1 |
8 review(s) available for isoxazoles and Rheumatism
| Article | Year |
|---|---|
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
[Gastrointestinal side effects in the therapy of rheumatologic diseases].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Etanercept; Gastrointestinal Diseases; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Stomach Ulcer; Sulfasalazine; Tumor Necrosis Factor-alpha | 2002 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
Novel therapies in pediatric rheumatic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Child; Genetic Therapy; Humans; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Neoplasm Proteins; Receptors, Tumor Necrosis Factor, Type II; Rheumatic Diseases; Rituximab; Sialoglycoproteins; Stem Cell Transplantation; Tumor Necrosis Factor Decoy Receptors | 2003 |
Rheumatological creativity and leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Isoxazoles; Leflunomide; Rheumatic Diseases | 2004 |
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.
Topics: Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pulmonary Wedge Pressure; Pyridazines; Rheumatic Diseases; Thiophenes; Treatment Outcome | 2005 |
[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Azathioprine; Biological Products; Cyclophosphamide; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Surgical Wound Infection; Tumor Necrosis Factor-alpha; Wound Healing | 2007 |
8 other study(ies) available for isoxazoles and Rheumatism
| Article | Year |
|---|---|
Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Brazil; Child; Contraindications; Female; Humans; Immunity, Innate; Immunization, Secondary; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Middle Aged; Retrospective Studies; Rheumatic Diseases; Rituximab; Scleroderma, Systemic; Yellow Fever; Yellow Fever Vaccine; Young Adult | 2015 |
Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
Topics: Abnormalities, Drug-Induced; Antirheumatic Agents; Chondrodysplasia Punctata; Ductus Arteriosus, Patent; Ectodermal Dysplasia; Female; Heart Block; Humans; Isoxazoles; Leflunomide; Pierre Robin Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Rheumatic Diseases; Spina Bifida Occulta | 2012 |
[Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclooxygenase Inhibitors; Diclofenac; Gastrointestinal Hemorrhage; Humans; Isoxazoles; Naproxen; Prognosis; Rheumatic Diseases; Sulfonamides | 2003 |
[Cardiovascular risks of Cox-2-antagonists. Opinion on the marketed name rofecoxib, and its market-withdrawn valdecoxib and the actual therapeutic restrictions].
Topics: Antirheumatic Agents; Cardiovascular Diseases; Consumer Product Safety; Cyclooxygenase Inhibitors; Drug Approval; Germany; Humans; Isoxazoles; Lactones; Practice Guidelines as Topic; Practice Patterns, Physicians'; Rheumatic Diseases; Sulfonamides; Sulfones | 2005 |
Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide.
Topics: Adult; Aged; Antirheumatic Agents; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Rheumatic Diseases | 2005 |
Angioinvasive aspergillosis presenting as neutropenic colitis.
Topics: Adalimumab; Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspergillosis; Cholecystectomy; Colitis; Colon; Diagnosis, Differential; Female; Hernia, Abdominal; Humans; Immunocompromised Host; Isoxazoles; Leflunomide; Pancytopenia; Rheumatic Diseases | 2006 |
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Congenital Abnormalities; Contraception; Contraception Behavior; Female; Health Surveys; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Outcome; Rheumatic Diseases | 2007 |
Clinical therapeutics.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Leflunomide; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |